Data and Insights

Beyond the App: Building a "One Touch, Always On" Digital Infrastructure for Universal Vaccination Access

Beyond the App: Building a "One Touch, Always On" Digital Infrastructure for Universal Vaccination Access

Privacy, simplicity, and universal access must be the pillars of any national vaccination reminder system. Introducing Vaccination Reminder.
The "Invisible Barrier" in Immunization: Why Supply Is No Longer the Only Challenge to European Public Health

The "Invisible Barrier" in Immunization: Why Supply Is No Longer the Only Challenge to European Public Health

Vaccine hesitancy is a loud problem, but "Vaccine Forgetfulness" is a silent epidemic. Tailored, authority-endorsed digital reminders are the missing infrastructure in our National Vaccination Strategies.
The 2.9% 'Launch Leak': Why Patient Churn Begins Immediately (And How to See It)

The 2.9% 'Launch Leak': Why Patient Churn Begins Immediately (And How to See It)

Our data shows nearly 3% of patients dropped off in the initial launch phase. If you wait for prescription refill data, you’re already too late.
The 61% Insight: Our Launch Data Reveals Most PSP Patients Are Enrolled Mid-Treatment, Not at Day 1

The 61% Insight: Our Launch Data Reveals Most PSP Patients Are Enrolled Mid-Treatment, Not at Day 1

If your Patient Support Program is built only for "new-to-therapy" patients, you're overlooking the majority. Are you supporting the right patient journey?
Data Shows 63% of Registered HCPs Don't Enroll a Single Patient. Here’s How to Bridge the 'Activation Gap.

Data Shows 63% of Registered HCPs Don't Enroll a Single Patient. Here’s How to Bridge the 'Activation Gap.

Launch data reveals a critical gap between HCP intent and action. How can pharma teams and physicians close it?
Beyond the Primary Prescriber: Analyzing PSP Adoption Trends Across Specialist Cohorts

Beyond the Primary Prescriber: Analyzing PSP Adoption Trends Across Specialist Cohorts

Launch data reveals a 137% gap in patient enrollment velocity between key specialists. How can pharma teams and HCPs bridge this disconnect?